Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127050701 | 12705070 | 1 | I | 20140923 | 20160823 | 20160831 | 20160831 | EXP | FR-ASTRAZENECA-2016SE91333 | ASTRAZENECA | 61.00 | YR | F | Y | 0.00000 | 20160831 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127050701 | 12705070 | 1 | PS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | U | U | 22101 | |||||||||
| 127050701 | 12705070 | 2 | SS | CANCIDAS | CASPOFUNGIN ACETATE | 1 | Intravenous (not otherwise specified) | Y | U | 0 | 70 | MG | QD | ||||||
| 127050701 | 12705070 | 3 | SS | VFEND | VORICONAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 127050701 | 12705070 | 4 | SS | LASILIX | FUROSEMIDE | 1 | Unknown | U | U | 0 | |||||||||
| 127050701 | 12705070 | 5 | C | ZYVOXID | LINEZOLID | 1 | 2 MG/ML | 0 | |||||||||||
| 127050701 | 12705070 | 6 | C | TIENAM | CILASTATIN SODIUMIMIPENEM | 1 | 2 MG/ML | 0 | |||||||||||
| 127050701 | 12705070 | 7 | C | CIPROFLOXACINE KABI | CIPROFLOXACIN | 1 | 400 MG/200 ML | 0 | |||||||||||
| 127050701 | 12705070 | 8 | C | AMIKACINE MYLAN | AMIKACIN | 1 | 1G | 0 | |||||||||||
| 127050701 | 12705070 | 9 | C | AMBISOME | AMPHOTERICIN B | 1 | 50 MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127050701 | 12705070 | 1 | Product used for unknown indication |
| 127050701 | 12705070 | 2 | Systemic candida |
| 127050701 | 12705070 | 3 | Fungal infection |
| 127050701 | 12705070 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127050701 | 12705070 | HO |
| 127050701 | 12705070 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127050701 | 12705070 | Acute generalised exanthematous pustulosis | |
| 127050701 | 12705070 | Blister | |
| 127050701 | 12705070 | Eosinophilia | |
| 127050701 | 12705070 | Hepatic function abnormal | |
| 127050701 | 12705070 | Multiple organ dysfunction syndrome | |
| 127050701 | 12705070 | Oedema peripheral | |
| 127050701 | 12705070 | Rash maculo-papular | |
| 127050701 | 12705070 | Renal impairment | |
| 127050701 | 12705070 | Septic shock | |
| 127050701 | 12705070 | Skin exfoliation | |
| 127050701 | 12705070 | Toxic skin eruption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127050701 | 12705070 | 1 | 201409 | 0 | ||
| 127050701 | 12705070 | 2 | 201409 | 20140925 | 0 | |
| 127050701 | 12705070 | 3 | 201409 | 0 | ||
| 127050701 | 12705070 | 4 | 201409 | 0 |